6137 search
Vertex Pharmaceuticals Incorporated
NASDAQ VRTX 490,32 US$ 20,50%
Logo

Are M&A Replacing R&D In Pharma?

Publié le 22 avril 2015

Pour voir l'article original, cliquez ici .

Les autres articles de la compagnie
Should Gilead Sciences Buy Vertex? Bernstein Says Yes, Maxim
Gilead's Stock Spikes on Possibility of Vertex Deal
Should Gilead Sciences Buy Vertex?
Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says
Will a New Vertex Drug for Cystic Fibrosis Become a Budget B
Articles en illimité et contenus premium Je m'abonne
Editoriaux
et Nouvelles
Actions
Minières
Or et
Argent
Marchés La Cote
search 6137
search